You are here

FDA

OARSI White Paper- OA as a Serious Disease

Various

~The Pre-Competitive Consortium for Osteoarthritis, an initiative of the Osteoarthritis Research Society International, submitted a White Paper entitled Osteoarthritis as a Serious Disease to the U.S. Food and Drug Administration on December 1, 2016.

Login to add comments.

Featured Resources

OARSI White Paper- OA as a Serious Disease

By Various

Patient Summary- Non Surgical Treatment of Knee Osteoarthritis

By Multiple Authors